Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells
about
The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancerTargeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitorsDevelopment and potential applications of CRISPR-Cas9 genome editing technology in sarcoma.Targeting CDK11 in osteosarcoma cells using the CRISPR-Cas9 system.Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapyUsing the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.Cyclin-dependent kinase 11(p110) (CDK11(p110)) is crucial for human breast cancer cell proliferation and growthCDK11 in TREX/THOC Regulates HIV mRNA 3' End Processing.Chromosomal Aberrations in Canine Gliomas Define Candidate Genes and Common Pathways in Dogs and Humans.Age-associated expression of HCN channel isoforms in rat sinoatrial node.Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to PaclitaxelAndrogen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11.The roles and therapeutic potential of cyclin-dependent kinases (CDKs) in sarcoma.Inhibitors of cyclin-dependent kinases as cancer therapeutics.Kinases Involved in Both Autophagy and Mitosis.DNA methylation of the CDC2L1 gene promoter region decreases the expression of the CDK11p58 protein and reduces apoptosis in keloid fibroblasts.Reduced expression of HCN channels in the sinoatrial node of streptozotocin-induced diabetic rats.Identification and characterization of the BmCyclin L1-BmCDK11A/B complex in relation to cell cycle regulation.Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cells.
P2860
Q26751387-0C28C61A-2ABA-4CDC-AB4D-CB029E41EA57Q26827580-3E8D1BFB-BCB9-4471-88E9-46AD9B3733BBQ34045952-29897506-17C3-4CF2-99DA-EAA4AECF43AFQ35007531-C073DAD5-C2B5-4373-869B-11F12C38941DQ35132090-140659A3-E4C3-4DEE-98C2-D723FE14317EQ35602598-41EF4B99-A335-4C88-81AF-8F7066CB9DA0Q35626610-D357EED1-B6B0-4E5F-B6FF-DFCDEDD51106Q36289312-CD554408-957C-4CB1-9A7A-22B59C882EDEQ37019743-836B95F4-C742-4E61-8977-3AD548BADDA5Q37071673-418983E4-2F75-4CD6-8BF0-B8B5C4251C45Q37075249-EA3A7EA7-4852-4E69-8E62-EAC2AFE72CD5Q37682137-EB4A2350-A15D-4B07-A0B6-5B9975F2ECD0Q38669852-3FE97F62-9BAF-4526-BD18-2E6314D436C8Q39125016-A9C57FB8-21E8-4CE3-BD6E-ECFAC53EF98BQ41661088-719F7010-FB4E-493B-AFE4-F27B475D9996Q47331145-DC03325D-E70C-4710-9B75-DC7E4E53CFACQ50904736-2D8DE46F-285F-4D33-98B2-F033187C57A9Q51093920-1FBF1587-2C73-4254-BED3-BFD322E84AA8Q52641599-674BE318-FD4F-4B02-9B06-4E778B7D3478
P2860
Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells
@ast
Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells
@en
Cyclin-dependent kinase 11
@nl
type
label
Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells
@ast
Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells
@en
Cyclin-dependent kinase 11
@nl
prefLabel
Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells
@ast
Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells
@en
Cyclin-dependent kinase 11
@nl
P2093
P2860
P1433
P1476
Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells
@en
P2093
David Harmon
Francis Hornicek
Henry Mankin
Quancheng Kan
Zhenfeng Duan
P2860
P304
P356
10.1016/J.CANLET.2013.08.040
P407
P577
2013-09-02T00:00:00Z